Is Geron Corporation's (NASDAQ:GERN) CEO Being Overpaid?

Chip Scarlett became the CEO of Geron Corporation (NASDAQ:GERN) in 2011. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. After that, we will consider the growth in the business. Third, we'll reflect on the total return to shareholders over three years, as a second measure of business performance. This process should give us an idea about how appropriately the CEO is paid.

See our latest analysis for Geron

Advertisement

How Does Chip Scarlett's Compensation Compare With Similar Sized Companies?

Our data indicates that Geron Corporation is worth US$272m, and total annual CEO compensation was reported as US$2.8m for the year to December 2018. We think total compensation is more important but we note that the CEO salary is lower, at US$667k. We note that more than half of the total compensation is not the salary; and performance requirements may apply to this non-salary portion. We examined companies with market caps from US$100m to US$400m, and discovered that the median CEO total compensation of that group was US$1.1m.

As you can see, Chip Scarlett is paid more than the median CEO pay at companies of a similar size, in the same market. However, this does not necessarily mean Geron Corporation is paying too much. A closer look at the performance of the underlying business will give us a better idea about whether the pay is particularly generous.

You can see a visual representation of the CEO compensation at Geron, below.

NasdaqGS:GERN CEO Compensation, January 27th 2020
NasdaqGS:GERN CEO Compensation, January 27th 2020

Is Geron Corporation Growing?

Over the last three years Geron Corporation has shrunk its earnings per share by an average of 4.1% per year (measured with a line of best fit). In the last year, its revenue is down 25%.

Unfortunately, earnings per share have trended lower over the last three years. And the fact that revenue is down year on year arguably paints an ugly picture. It's hard to argue the company is firing on all cylinders, so shareholders might be averse to high CEO remuneration. Shareholders might be interested in this free visualization of analyst forecasts.

Has Geron Corporation Been A Good Investment?

Since shareholders would have lost about 31% over three years, some Geron Corporation shareholders would surely be feeling negative emotions. This suggests it would be unwise for the company to pay the CEO too generously.

In Summary...

We compared the total CEO remuneration paid by Geron Corporation, and compared it to remuneration at a group of similar sized companies. We found that it pays well over the median amount paid in the benchmark group.

Neither earnings per share nor revenue have been growing sufficiently to impress us, over the last three years. Just as bad, share price gains for investors have failed to materialize, over the same period. In our opinion the CEO might be paid too generously! If you think CEO compensation levels are interesting you will probably really like this free visualization of insider trading at Geron.

If you want to buy a stock that is better than Geron, this free list of high return, low debt companies is a great place to look.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

About NasdaqGS:GERN

Geron

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Undervalued with high growth potential.

Advertisement

Weekly Picks

CE
Ceazar
CNXU logo
Ceazar on Conexeu Sciences ·

This small biotech is developing technology that could potentially change how tissue is rebuilt

Fair Value:US$25.3450.6% undervalued
8 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HE
HedgeY
PWR logo
HedgeY on Quanta Services ·

The Picks-and-Shovels Leader of the Grid Supercycle

Fair Value:US$7101.3% overvalued
11 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
FU
KRMN logo
FundamentalFlow on Karman Holdings ·

KRMN — Karman Space & Defense: Down 58% from Peak, Is the Market Mispricing a Hypergrowth Defense Compounder?

Fair Value:US$105.651.0% undervalued
7 users have followed this narrative
1 users have commented on this narrative
5 users have liked this narrative
DO
Double_Bubbler
IES logo
Double_Bubbler on Invinity Energy Systems ·

Invinity Energy Systems: All About That BESS

Fair Value:UK£163.7% undervalued
6 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

RO
Robbo
PRU logo
Robbo on Perseus Mining ·

Mega IPO Liquidity Cycles and Temporary Mispricing in Defensive Assets – A Perseus Mining Case Study

Fair Value:AU$7.9632.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YA
Yaser
SOXX logo
Yaser on iShares Trust - iShares Semiconductor ETF ·

SOXX – iShares Semiconductor ETFFull Analysis Report & EOY 2027 Fair Value Estimate

Fair Value:US$6407.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YA
Yaser
SCHG logo
Yaser on Schwab Strategic Trust - Schwab U.S. Large-Cap Growth ETF ·

SCHG – Schwab U.S. Large-Cap Growth ETF: Full Analysis & 2026 Fair Value Report

Fair Value:US$3810.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7444.1% undervalued
66 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9635.2% undervalued
54 users have followed this narrative
8 users have commented on this narrative
17 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1928.3% undervalued
51 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative